echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Chen Jianfeng's group collaborated to discover a new mechanism by which different chemokines regulate the binding of integrin α4β7 to HIV-1 virus

    Chen Jianfeng's group collaborated to discover a new mechanism by which different chemokines regulate the binding of integrin α4β7 to HIV-1 virus

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    <>.


    After HIV (Human immunodeficiency virus, HIV) -1 virus infects the human host, it replicates in large amounts in Gut-associated lymphoid tissue (GALT), and infects CD4 + T cells to gradually deplete it, triggering acquired Acquired immune deficiency syndrome (Acquired immune deficiency syndrome, AIDS)


    Chen Jianfeng's team found that inactive integrin α4β7 cannot bind to gp120, and only when integrin α4β7 is highly activated can it bind to gp120


    In summary, this study reveals that specific chemokines in the intestine can promote the binding of α4β7 and HIV-1 virus gp120 by causing a specific activation conformation of integrin α4β7, and activate multiple intracellular signaling pathways, ultimately promoting HIV -1 infection of T cells


    Researcher Chen Jianfeng from the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences is the corresponding author, researcher Li Guohui and Associate Researcher Zhang Yuebin from Dalian Institute of Chemical Physics, Chinese Academy of Sciences are the co-corresponding authors, and Dr.


    Article link: https://#Sec1

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.